You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Litigation Details for ELI LILLY AND COMPANY v. NANG KUANG PHARMACEUTICAL CO., LTD. (S.D. Ind. 2014)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in ELI LILLY AND COMPANY v. NANG KUANG PHARMACEUTICAL CO., LTD.
The small molecule drugs covered by the patent cited in this case are ⤷  Try a Trial and ⤷  Try a Trial .

Details for ELI LILLY AND COMPANY v. NANG KUANG PHARMACEUTICAL CO., LTD. (S.D. Ind. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-10-08 1 expiration of U.S. Patent Nos. 5,344,932 (“the ’932 patent”) and 7,772,209 (“the ’209 patent”). ALIMTA ® is… (Infringement of U.S. Patent No. 7,772,209) 33. Plaintiffs incorporate…Attachments: # 1 Exhibit A - '932 Patent, # 2 Exhibit B - '209 Patent, # 3 Civil Cover Sheet, # 4 Proposed… 1. This is an action for patent infringement under the patent laws of the United States, Title…. The ’932 patent is attached as Exhibit A hereto. 14. The ’209 patent, titled “Antifolate External link to document
2016-07-01 119 Defendants infringe Lilly’s U.S. Patent No. 7,772,209 (“the ’209 patent”) based on the filing of Abbreviated…claims of the ’209 patent with the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office…of the ’209 patent. Defendants have also all alleged that the claims of the ’209 patent are invalid. …the ’209 patent were invalid and that the defendants in that action infringed the ’209 patent. That action… 1. This is a consolidated action for patent infringement. Lilly has alleged that each of External link to document
2014-11-06 34 those patents has been the subject of Hatch-Waxman litigation before. One patent (U.S. Patent No. 7,…1469-TWP-DKL. The second patent (U.S. Patent No. 5,344,932, “the ’932 patent”), which is owned by Plaintiff…This is a Hatch-Waxman pharmaceutical patent case about two patents protecting the blockbuster anti-cancer… trigger a patent infringement lawsuit, and thereby challenge the validity of the patents covering an… that the ’932 patent is not infringed. And while it did assert that the ’209 patent is not infringed External link to document
2015-08-24 59 claims of U.S. Patent Nos. 5,344,932 (the “‘932 patent”) and 7,772,209 (the “‘209 patent”) are invalid… I. BACKGROUND This Hatch-Waxman patent infringement case arises from Nang Kuang’s submission…offer for sale of the ANDA Products. The ‘932 patent is owned by the Trustees of Princeton University…covers Lilly’s anti-cancer drug pemetrexed. The ‘209 patent is owned by Lilly and is directed to methods …folic acid and vitamin B 12. Lilly sells the patented drug and its associated method of administration External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.